Fumaric Acid

Fumaric Acid

SCHEMBL23927898

CN(C)CCCn1ccc2ccccc21.O=C(O)/C=C/C(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HTR2A known ✓ P28223 1/20 0.62
▸ HTR2C known ✓ P28335 1/20 0.62
▸ KMT2A known ✓ Q03164 2/20 0.49
▸ DRD2 known ✓ P14416 1/20 0.47
▸ MEN1 known ✓ O00255 1/20 0.47
▸ CDK4 P11802 4/20 0.54
▸ CCND1 P24385 4/20 0.54
▸ SMPD1 P17405 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ DRD4 P21917 1/20 0.47
▸ DRD3 P35462 1/20 0.47
▸ HTR1D P28221 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL29435344 1.00 HTR2A (0.62) HTR2AHTR2CCDK4CCND1SMPD1
Fumaric Acid SCHEMBL23927822 0.92 HTR2C (0.75) HTR2AHTR2CCDK4CCND1MAPK1
Fumaric Acid SCHEMBL29435341 0.92 HTR2C (0.75) HTR2AHTR2CCDK4CCND1MAPK1
SCHEMBL3990419 0.87 HTR2C (0.81) HTR2AHTR2CCDK4CCND1SMPD1
Hydrochloric Acid SCHEMBL11486417 0.86 HTR2A (0.78) HTR2AHTR2CCDK4CCND1SMPD1
Fumaric Acid SCHEMBL9434866 0.83 PDPK1 (0.47) HTR2AHTR2CCDK4CCND1SMPD1
SCHEMBL4060777 0.78 HTR2C (1.00) HTR2AHTR2CCDK4CCND1MAPK1
SCHEMBL6754275 0.75 PLG (0.51) HTR2AHTR2C
Fumaric Acid SCHEMBL23927905 0.74 HTR2A (0.56) HTR2AHTR2CCDK4CCND1HTR1D
Fumaric Acid SCHEMBL23927927 0.74 HTR2A (0.49) HTR2AHTR2CHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-02-22 — — US disclosed
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA CORPORATION 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11254640-B2 N-substituted indoles and other heterocycles for treating brain disorders TPH2, AANAT, HTR2C HTR2A 5/4885HTR2C 3/4885KMT2A 542/4885
US-20210332012-A1 N-SUBSTITUTED INDOLES AND OTHER HETEROCYCLES FOR TREATING BRAIN DISORDERS TPH2, AANAT, HTR2C HTR2A 5/4885HTR2C 3/4885KMT2A 542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback